I don't have much context, but the identification of the AHR receptor for the CXCL seems like the exciting part. From what I understand, it is easy enough to d

I don't have much context, but the identification of the AHR receptor for the CXCL seems like the exciting part. From what I understand, it is easy enough to design an antibody once you know the right receptor to target